Ten Years of Antipsychotic Prescribing to Children: A Canadian Population-Based Study

Trends in Psychostimulant and Antidepressant Use by Children in 2 Canadian Provinces

(2017) Brendon Mitchell et al.   CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE

Increased Prevalence of Obesity and Glucose Intolerance in Youth Treated with Second—Generation Antipsychotic Medications

(2017) Constadina Panagiotopoulos et al.   CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE

Letter

(2015) Ingrid Schubert et al.   PSYCHIATRIC SERVICES

Utilization and Costs of Antipsychotic Agents: A Canadian Population-Based Study, 1996–2006

(2014) Silvia Alessi-Severini et al.   PSYCHIATRIC SERVICES

Use of Antipsychotic Drugs Among Dutch Youths Between 1997 and 2005

(2014) Luuk J. Kalverdijk et al.   PSYCHIATRIC SERVICES

Effect of Treatment on Weight Gain and Metabolic Abnormalities in Patients with First-Episode Psychosis

(2009) Swapna Verma et al.   AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY

A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder

(2009) Melissa P DelBello et al.   BIPOLAR DISORDERS

Efficacy, safety and tolerability of two risperidone dosing regimens in adolescent schizophrenia: double-blind study

(2009) Magali Haas et al.   BRITISH JOURNAL OF PSYCHIATRY

Paediatric Atypical Antipsychotic Monitoring Safety (PAMS) Study

(2009) Fariz A. Rani et al.   DRUG SAFETY

The Role of Antipsychotics in the Management of Behavioural Symptoms in Children and Adolescents with Autism

(2009) Richard P. Malone et al.   DRUGS

Rise in psychotropic drug prescribing in children and adolescents during 1992–2001: a population-based study in the UK

(2009) Yingfen Hsia et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents

(2009) Christoph U. Correll   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Hyperprolactinemia-Related Adverse Events Associated with Antipsychotic Treatment in Children and Adolescents

(2009) Jeanette M. Jerrell et al.   JOURNAL OF ADOLESCENT HEALTH

Methylphenidate Combined with Aripiprazole in Children and Adolescents with Bipolar Disorder and Attention-Deficit/Hyperactivity Disorder: A Randomized Crossover Trial

(2009) Cristian Patrick Zeni et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Determinants of Initial Pharmacological Treatment for Youths with Attention-Deficit/Hyperactivity Disorder

(2009) Chih-Ying Chen et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Weight Gain and Metabolic Abnormalities During Extended Risperidone Treatment in Children and Adolescents

(2009) Chadi A. Calarge et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Neuroleptic Malignant Syndrome in Children and Adolescents on Atypical Antipsychotic Medication: A Review

(2009) Rachel Neuhut et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of Methylphenidate Transdermal System in Pediatric Patients With Attention-Deficit/Hyperactivity Disorder

(2009) Robert L. Findling et al.   JOURNAL OF CLINICAL PSYCHIATRY

Metabolic and Cardiovascular Adverse Events Associated With Antipsychotic Treatment in Children and Adolescents

(2008) Roger S. McIntyre et al.   ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE

Epidemiologic Features of Antipsychotic Prescribing to Children and Adolescents in Primary Care in the United Kingdom

(2008) F. Rani et al.   PEDIATRICS